MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,

Slides:



Advertisements
Similar presentations
Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
Advertisements

1 Household Survey on Medicine Use in Oman Ahmed Abdo-Rabbo, Manal Al- Ansari, Brian Gunn, Batool Suleiman & Hawraa Al-Lawati Directorate of Rational Use.
ECONOMIC ASSESSMENT OF IMPLEMENTATION TREATMENT GUIDELINES OF HYPERTENSION IN OUT-PATIENT PRACTICE Kulmagambetov IR Karaganda State Medical Academy, Kazakhstan.
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
Antibiotic Policy in Ghana; the way forward
Comprehensive M&E Systems
Drug and Therapeutics Committee Session 7A. Identifying Problems with Medicine Use: Indicator Studies.
1 Drug and Therapeutics Committee Session 10. Standard Treatment Guidelines.
EDM STRATEGY FOR WORKING WITH COUNTRIES-TANZANIA Rose Shija EDM NPO TANZANIA.
Generating evidence for change: Implementing the post-ICIUM research agenda Dennis Ross-Degnan, ScD Harvard Medical School and Harvard Pilgrim Health Care.
Whilst the pharmaceutical industry plays a key role in developing and producing medicines, there is a tension between industry’s need to expand product.
Impact of a public education program on promoting rational use of medicines: a household survey in south district of Tehran, Darbooy SH, Hosseini.
WHO Level II Facility Surveys Douglas Ball Independent consultant, UK.
Use of an Indicator-Based System for Assessing, Monitoring, and Improving Pharmacy Practice Authors: Lates, J. (1); Sumbi, V. (2); Phulu, B. (1); Rushubiza,
Using Longitudinal Data for Evaluating Policy Changes and Other Interventions -Information system in Tamilnadu Medical Services Corporation.
Effects of an Intervention on the Use of Medicines in Herat Province of Afghanistan Bapna, Jawahar Singh (1); Aaen, Inge-Lise (2); Hamedi, Saeed (2)
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
Accessibility of Essential Drugs in Remote Areas of Laos Sivong SENGALOUNDETH, Bounnao PHACHOMPHONH, Sivixay XAYASAN Khamveuy THAMMAKHANH, Vongchanh PHANOUVONG.
Introduction to Elements of In-Country Drug Management with Focus on TB Drugs Jim Rankin Director, Center for Pharmaceutical Management Management Sciences.
ASSESSMENT OF AVAILABILITY, PRICE AND AFFORDABILITY OF MEDICINES FOR CHILDREN IN GHANA Authors: Gyansa-Lutterodt M. 1,Andrews Annan E. 2, Koduah A. 1,
The Pharmaceutical Situational Analysis in Mongolia 1 Chimedtseren Munkhdelger 1 Sanjjav Tsetsegmaa 2, 1 Ministry of Health, 2 Pharmacy School, Health.
Report on the Evaluation Function Evaluation Office.
Margarit MELIKYAN Drug Utilization Research Group PO, Armenia, National Institute of Health Access to and Use of Medicines by Households in Armenia: Impact.
OVERVIEW OF THE ZIMBABWE NATIONAL MEDICINES POLICY Dr C E Ndhlovu, M Med Sci, FRCP Chairperson, NMTPAC Deputy Dean, UZCHS National workshop, Jan 22-23,
Problem Statement: In Kenya, despite the development of national standard treatment guidelines (STGs) for the management of acute respiratory infections.
Improving Access and Use of Medicines through Private Sector Initiatives: A case for an Essential Medicines Franchise in Ghana Eghan Kwesi, Mensah D, Idun.
Policy track summary ICIUM 2011 – 18 Nov Policy track topics 1.The pharmaceutical policy process 2.Quality and safety of medicines in LMIC 3.Policy.
BASELINE SURVEYS AND MONITORING OF PHARMACEUTICAL SITUATION IN COUNTRIES. Joseph Serutoke NPO/EDM WHO Uganda November 2002.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Abstract ID: 481 Author Name: Ebba Holme Hansen Presenter Name: Kumud K. Kafle Authors: Hansen EH, Kafle KK, Karkee SB, Onta SR, Subba.
Promoting Drug and Therapeutics Committees in the Developing World
Yemaneberhan Taddesse.  PASDEP(plan of accelerated and sustainable development for the Eradication of poverty) Poverty reduction strategy is the main.
Objective the aim of this project was directly addressing a major health problem for Jordan by producing a guideline as a pilot in which the strengths.
Abstract ID: 395 Author Name: Araya Sripairoj Presenter Name: Araya Sripairoj Authors: Sripairoj A, Liamputtong P, Harvey K.
A BASELINE SURVEY OF THE PHARMACEUTICAL SECTOR IN TANZANIA
Development and Implementation of Good Pharmacy Practice Standards in Developing Countries Author: Frokjaer B, International Pharmaceutical Federation.
Abstract Impact of the Essential Drugs Programme at the Primary Health Care Level in South Africa Hela M, Zeeman H, Department of Health South Africa;
Promoting Rational Use of ARVs in HIV/AIDS Clinics in Tanzania Presented by Salama Mwakisu -MSH.
An Intervention To Improve Antibiotic Prescribing Habits of Doctors in a Teaching Hospital Ofei F, Forson A, Tetteh R, Ofori-Adjei D University of Ghana.
TBS 2008-H. Tata & M. Babaley Mapping and In-depth Assessment of Medicines Procurement and Supply Systems WHO Technical Briefing Seminar 17 th -21 st November.
Indicators for monitoring and assessing pharmaceutical situation in countries.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
ABSTRACT THE CHALLENGE OF INTEGRATING A RDU TRAINING MODEL INTO THE REALITY OF A HEALTH SYSTEM CONTEXT Problem Statement: The Dar es Salaam Urban Health.
Authors: Lates JA, Shiyandja NN Funding Institution: Ministry of Health and Social Services, Namibia Title: Third National Survey on the Use of Drugs in.
MONITORING MEDICINE AVAILABILITY AND PRICES IN UGANDA By Denis Kibira HEPS Uganda.
Indicators for monitoring and assessing pharmaceutical situation in countries Dr. Edelisa D. Carandang Drug Action Program (DAP) Essential Drugs and Medicines.
WHO Medicines Strategy Progress: Priorities: Dr Guitelle Baghdadi Essential Drugs and Medicines Policy World Health Organization November.
Quality Care Standards Authors: Frokjaer B, Grant RL Problem Statement: All practicing pharmacists are obliged to ensure that the service they provide.
RECENT ADVANCES IN PROVISION OF PRIMARY HEALTH CARE BY MISSION ORGANIZATIONS THE EFFECT OF AN EDUCATIONAL INTERVENTION ON USE OF ANTIBIOTICS IN THE TREATMENT.
Learning About Drug Use1 An Overview of the Process of Changing Drug Use 1. EXAMINE Measure Existing Practices (Descriptive Quantitative Studies) 2. DIAGNOSE.
Does Drug Use Evaluation Required by National Policy Improve Use of Medicines? Akaleephan C*, Muenpa R**, Sittitanyakit B***, Treesak C #, Cheawchanwattana.
ICIUM 2004-CHIANG MAI SURVEY REPORT ON RATIONAL USE OF DRUGS In 30 Primary Health Centres of Tamilnadu, India.
ADDRESSING PHARMACEUTICAL SUPPLY CHAIN NEEDS PRESENTATION TO HEALTH DONOR GROUP MEETING 8 July 2009.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
WHO Estonia country office Marge Reinap Head of WHO Country Office in Estonia.
ABSTRACT THE IMPACT OF CONTINUOUS MEDICAL EDUCATION ON PRESCRIBING HABITS IN MISSION HOSPITALS IN KENYA By John Kiambuthi Mission for essential drugs and.
Zambia’s Country Experiences
Implementing the guideline
WHO Medicines Work in Countries: The Kenya Example
Logez S, Hutin Y, Somda P, Thualt J, Holloway K
ABSTRACT THE IMPACT OF CONTINUOUS MEDICAL EDUCATION ON PRESCRIBING
SUNARTONO HEAD OF SLEMAN DISTRICT HEALTH OFFICE, INDONESIA
ABSTRACT Problem statement: The Lao PDR National Drug Policy (NDP) Program, implemented by the Ministry of Health supported by the Swedish International.
Trap B and Hansen EH Euro Health Group, Denmark &
Kandeke C, Chibuta C, Banda D
Adherence, attitude to Standard Treatment Guidelines in clinical practice at tertiary care hospitals in Delhi State 1Sangeeta Sharma, 2Sharma KK, 3Sethi.
Pharmacy practice and the healthcare system Ola Ali Nassr
Toktobaeva B, Karymbaeva S Drug Information Centre Kyrgyzstan
Access to Essential Medicines
Zambia’s Country Experiences
Presentation transcript:

MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7, Osei I 5, Ofori-Adjei D 3,7, Asiamah D 1,7, Dodoo A 6,7, 1 Ghana National Drugs Programme, Ministry of Health, 2 WHO/Ghana, 3 Noguchi Memorial Institute for Medical Research, University of Ghana, 4 University of Memphis, Tennessee, USA, 5 Ghana Health Service, 6 Centre for Tropical Clinical Pharmacology and Therapeutics, University of Ghana Medical School, University of Ghana, 7 INRUD-Ghana

Monitoring the Pharmaceutical Sector 2 Abstract Abstract ID: 553 Monitoring the Pharmaceutical Sector in the Developing World: The Ghana Example Gyansa-Lutterodt M, Andrews E, Arhinful D, Addo-Atuah J, Osei, I, Ofori-Adjei D, Asiama D, Dodoo A Ghana National Drugs Programme (Ministry of Health), World Health Organization/Accra, INRUD-Ghana Core Group, Problem Statement: The Ghana National Drugs Programme was introduced in 1997 as part of a first Five-Year Medium-Term Strategic Framework (1997–2001) for health development in Ghana. The aim of the program is to improve access to essential medicines and ensure that medicines are used rationally. Although monitoring of the sector is ongoing, it was necessary to evaluate the interventions after several years of implementation to determine the current situation and measure any gains. Objectives: To define the current status of the pharmaceutical sector in Ghana in relation to rational use of medicines and drug management (including storage facilities and access to medicines), and to compare the findings with baseline data gathered in Design: Cross-sectional descriptive study. Setting and Study Population: Public and private health facilities at regional, district, and sub-district levels. A household survey was also carried out. Four regions of the country were purposively selected based on their socioeconomic profile. The study units comprised primary care facilities, pharmacies in the public and private sectors, public drug warehouses, and households within five kilometers of a public health facility. Interventions: Training of dispensers and prescribers; feedback about prescribing habits; provision of Standard Treatment Guidelines (STGs) and the Essential Medicines List (EML) to health professionals and institutions. Outcome Measures: Percentage outcomes of prescribing indicators, patient care indicators, facility indicators, and access to medicines (including availability and affordability). Results: Improvements were noted in average number of drugs prescribed (4.6–3.5), percentage of antibiotic use (56–42.5%), and percentage of injection use (42–33.5%). The Ghana STGs and EML were available in 90% of facilities, but adherence is far from satisfactory; for example, antibiotic use in acute respiratory infection was high at 76.1%. Of the medicines prescribed to outpatients, 91.23% were dispensed to them. Although adequacy of labeling is poor, 58.13% of patients had adequate knowledge of drugs dispensed to them. The average number of stock-out days in public facilities was 60.5 days, compared to 0 days in private outlets. Many households (66.7%) seek medication from health facilities, but private drug outlets are also popular sources, being utilized by 32.4% of households with ill members. Self-medication was observed in 8.1% of households. Conclusions: The drug use situation appears to have improved since 1998, but there is room for further improvement. Attention must be focused on reducing high injection and antibiotic use by prescribers. Greater efforts should be directed at drug management practices in public drug outlets to improve their efficiency. More research is necessary to assess the outcomes comprehensively. Study Funding: WHO, Royal Netherlands Government, Ministry of Health

Monitoring the Pharmaceutical Sector 3 Introduction The Ghana National Drugs Programme – (GNDP) was implemented as a 5-year comprehensive pharmaceutical sector development programme from 1997 onwards. It is part of Ghana’s first Five-Year Medium Term Strategic Framework ( ). The goal of the programme is to ensure that all people in Ghana have access to effective safe and affordable drugs of good quality in both the public and the private sector, and that these are rationally used.

Monitoring the Pharmaceutical Sector 4 Background The Ghana National Drugs Programme (GNDP) was established in 1997 to coordinate a fully comprehensive pharmaceutical sector development programme in several areas including: The development, implementation and monitoring of pharmaceutical policy Improving access to medicines by improving –The financing mechanism for pharmaceuticals and –Supply of pharmaceuticals & allied products Strengthening quality assurance systems in pharmaceuticals to deliver quality products and services and Promoting rational use of medicines by health professionals and consumers through drug regulation initiatives, pharmacy practice, capacity building, drug procurement and improvements in the practice of traditional medicine

Monitoring the Pharmaceutical Sector 5 Study Objective To define current status of the pharmaceutical sector in Ghana in relation to 1. Rational drug use –Describe prescribing patterns and dispensing practices 2. Drug management and medicines storage –Describe drug expiry, stock outs periods and storage conditions of the medicines 3. Access to medicines –Determine the availability and affordability of key drugs  To compare findings with 1998 baseline results To evaluate the impact of planned regular monitoring on achievement of programme objectives

Monitoring the Pharmaceutical Sector 6 Methodology Public and private health facilities were studied at regional, district, and sub-district levels. The study units comprised public health facilities, community pharmacies, public drug warehouses and households within five kilometers of a public health facility The design was cross sectional & descriptive –Rational use of medicines in public facilities –Drug availability and affordability in both public and private sectors –Household surveys Data collection methods used comprised: - Interviews, Observations and Review of existing records and registers

Monitoring the Pharmaceutical Sector 7 Interventions 1 Interventions carried out to date include: Rational Use of Medicines  Selection, training and monitoring of Regional Focal Persons;  Training of dispensers and prescribers in all regions;  Provision of Standard Treatment Guidelines (STGs) & Essential Medicines List (EML) to health professionals and institutions;  Monitoring by regional focal persons and activity-linked disbursement of funds and  Regular monitoring, feedback and visits by/from GNDP Coordinating Unit;

Monitoring the Pharmaceutical Sector 8 Interventions 2 Quality and Safety of Medicines –The Food and Drugs Board has been strengthened through the installation and training in SIAMED and competence development in evaluating dossiers of generic medicines including ARV’s; –Standards for pharmacy premises and practice developed and published awaiting dissemination –National Centre for Pharmacovigilance established and fully functional Access –A fully functional procurement unit, –Quantification of drugs/procurement audit; –Process of local production of ARV’s being considered Policy –Review of National Drug Policy completed –Collaboration with MSH/ SEAM Initiative to ensure access –Traditional and Alternative Medicine Directorate Training manual completed

Monitoring the Pharmaceutical Sector 9 Outcome Measures This focused on Rational use of medicines and access and comprised :-  Percentage outcomes of prescribing indicators,  Patient care indicators,  Facility indicators and  Access to medicines (including availability and affordability

Monitoring the Pharmaceutical Sector 10 Results I – The Indicators Indicator Av. No Drugs/encounter % Antibiotic % Injection % Drugs on EDL % Availability of STG Availability of medicines Compared to 1998 improvements were noted in the Prescribing and Facility Care Indicators

Monitoring the Pharmaceutical Sector 11 Results II Average number of stock-out days in public facilities was 60.5 days, compared to 0 days in private outlets Adequacy of labeling– <1% Patients knowledge of dispensed drugs 58.13% Household utilization of health facilities % public and 32.4% private

Monitoring the Pharmaceutical Sector 12 Recommendations Appropriate and dynamic interventions are required to improve rational use of medicines in developing countries Activity linked disbursement of funds promotes adherence to set targets Regular monitoring and surveys are essential to evaluate gains to guide future interventions

Monitoring the Pharmaceutical Sector 13 Conclusions The implementation of the GNDP in 1997 has led to improvements in some drug use indicators in Ghana The decentralized implementation systems with feedback to central coordinating unit has facilitated some of the achievements Both centralized and decentralized systems of monitoring were key to success